Recurrent Multiple Myeloma Clinical Trials

ReadTheTrial indexes 1 studies for Recurrent Multiple Myeloma. The most common development stage is Phase 1 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Recurrent Multiple Myeloma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 1
100%

Trial Status Breakdown

Trials for Recurrent Multiple Myeloma

A Phase 1b Trial of Teclistamab in Combination With Iberdomide for Relapsed/Refractory Multiple Myeloma

NCT06465316 · RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Recurrent Multiple Myeloma?

There are 1 clinical trials listed for Recurrent Multiple Myeloma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Recurrent Multiple Myeloma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Recurrent Multiple Myeloma trials in?

Current Recurrent Multiple Myeloma trials are distributed across: Phase 1 (1).

Find More Trials